The Latest Breaking News from Omicron

‘Living with the virus’ is proving much harder than the early vaccine success suggested, says professor of immunology Danny Altmann

Total infections are now at levels last seen in late April.

With immunity waning and the super-contagious omicron family of variants getting better at dodging protection, the Food and Drug Administration decided boosters intended for fall needed an update.

While vaccinations have greatly cut down on hospitalizations and deaths, COVID-19 cases are on the rise again around the world.

U.S. regulators are telling COVID-19 vaccine makers to tweak any booster doses intended for fall so they protect against the newest omicron relatives

The growing prevalence of the virus is likely to cause fresh disruption to public services

The growing prevalence of the virus could cause fresh disruption to public services.

Pfizer Inc (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) have announced a new vaccine supply agreement with the U.S. government. Under the agreement, the U.S. government will receive 105 million doses (30 µg, 10 µg and 3 µg). This may include adult omicron-adapted COVID-19 vaccines, subject to the FDA authorization.  The doses are planned to be delivered…

The FDA will have to decide the exact recipe. But expect a combination shot that adds protection against omicron or some of its newer relatives to the original vaccine.